Thank you for subscribing!
Next Investors Archived Dec 04, 2017
It has been a major month for Creso Pharma (ASX:CPH) as it continues to make potentially market moving announcements.
Next Investors Archived Nov 23, 2017
MGC Pharmaceuticals (ASX:MXC) was the second company to originally emerge in the ASX cannabis corridor, and with a whip-smart team that’s put in serious hours in the industry-leading Israeli medicinal marijuana scene, this ASX junior is rapidly coming into its own.
Finfeed Archived Nov 22, 2017
Creso Pharma Limited (ASX:CPH) today announced it had secured an important deal with its Australian distribution partner, Health House International, for the import and distribution of its first cannabinoid-based human health product.
Finfeed Archived Sep 25, 2017
Diversified investment group, Chapmans Limited (ASX:CHP), has announced the company’s successful completion of its strategic investment in MJ Life Sciences (MJLS).
Get expert stock analysis direct in your inbox
Finfeed Archived Aug 30, 2017
Diversified investment group, Chapmans (ASX: CHP) announced on Tuesday that it had entered into a binding Heads of Agreement (HOA) with MJ Life Sciences (MJLS) with a view to making a strategic investment of $500,000 in MJLS, an Australian special-purpose company established with the aim of becoming a leading global medicinal cannabis holding and investment company.
Catalyst Hunter Archived Aug 06, 2017
CPH is a leading player in medicinal cannabis and cannabidiol (CBD) innovation, and develops cannabis and hemp-derived therapeutic-grade CBD nutraceuticals and medicinal cannabis products with wide patient and consumer reach for both human and animal health.
Finfeed Archived Jul 28, 2017
Creso Pharma Limited (ASX: CPH) has expanded into the Canadian market with the proposed acquisition of emerging Nova Scotia-based medicinal cannabis producer, Mernova Medicinal Inc (Mernova) for a total of C$10.1 million (A$10.2 million) in cash and equity.
Next Investors Archived Jul 27, 2017
Creso Pharma (ASX:CPH) is now in the box seat to acquire 100% of Canadian-based Mernova Medicinal Inc., an acquisition that would position CPH as a Canadian producer of legal cannabis.
Finfeed Archived Jun 26, 2017
Diversified investment company focused on high-growth market segments, Chapmans (ASX: CHP) announced on Friday that its specialist wholly owned medicinal cannabis subsidiary, Cannabis Investments Limited (CIL), had entered into a Term Sheet with AZ Pharmaceuticals Inc., the owner of the Aunt Zelda’s medicinal cannabis business, to invest US$2 million in Aunt Zelda’s.
Next Investors Archived Jun 16, 2017
Chapmans Ltd (ASX: CHP) is not the typical stock readers are accustomed to seeing here at The Next Small Cap. In fact, after scratching our collective temples, we couldn’t find any previous instances of us delving into a Listed Investment company (LIC).
Next Investors Archived Jun 14, 2017
News of $100 million IPOs, alongside an avalanche of parallel legislative changes around the world, builds a strong case for the burgeoning medicinal marijuana industry. With so many medicinal cannabis stocks fighting for market share and threatening to steal the limelight, a company such as Creso Pharma Ltd (ASX: CPH) needs to do all it can to stay current and competitive.
Finfeed Archived Jun 01, 2017
Creso Pharma Limited (ASX:CPH) has signed a binding Letter of Intent (LOI) with Cannapharm AG to provide patients in Asia Pacific and Latin America (LATAM) access to top quality medicinal cannabis products from Switzerland.
Finfeed Archived May 11, 2017
Creso Pharma Limited (ASX:CPH) has signed a strategic agreement with pre-eminent Australian medicinal cannabis producer LeafCann Group Pty Ltd (LeafCann).
Finfeed Archived May 02, 2017
Shares in Creso Pharma (ASX:CPH) could receive significant support after the company announced that it had formalized an agreement with its partner in Australia, Health House International Pty Ltd (Health House), following Health House’s successful import of the first medicinal cannabis products into Australia. It should be noted that share trading patterns should not be
Next Investors Archived May 02, 2017
Creso Pharma (ASX: CPH) has made a shipment of medicinal cannabis into Australia – the first import into the country under new government legislation. Under an agreement between CPH and its Australian partner, Health House International Pty Ltd, the pair will distribute a range of cannabis oil products across Australian pharmacies, in compliance with Federal and State legislation.
Finfeed Archived Mar 30, 2017
The share price of Capital Mining (ASX: CMY) doubled in the first hour of trading on Wednesday morning after the company announced that an agreement had been reached with medical cannabis group Broken Coast Cannabis Limited (BCC).
Next Investors Archived Mar 22, 2017
There is no doubt about it – medical marijuana stocks are lighting up the ASX right now, as the mainstream media and investment community at large is finally starting to pick up on what we have been saying for over 12 months now.
Next Investors Archived Mar 01, 2017
Creso Pharma (ASX:CPH) is one company set to benefit from the Australian Federal Government’s move this month to improve access to medical cannabis and grant import/export licenses.
Join Our Mailing List
